Clinical trial · Interventional
Radiofrequency Ablation (RFA) in Breast Tumors
Radiofrequency Ablation in Breast Tumors in Early Stages
NCT04389216CI-TRIAL-00095148RFAcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To validate the efficacy and safety of the cool-tip ablation method for breast tumors smaller than 2 cm.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cool-tip electrode for Radiofrequency Ablation | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Radiofrequency Ablation Tumor
- description
- Radiofrequency Ablation of breast cancer tumour by Cool-tip electrode.
- interventionNames
- Device: Cool-tip electrode for Radiofrequency Ablation
Primary outcomes (2)
- measure
- MRI post-RFA
- timeFrame
- "1 month"
- description
- Magnetic Resonance Image after Radiofrequency ablation to confirmate complete disappearance of tumor contrast enhancement (residual mm).
- measure
- BAG post-RFA
- timeFrame
- "1 month"
- description
- Breast biopsy after Radiofrequency to confirmate absence of viable tumor tissue using NADH, CK18 and CK19 stainings (tumor viability scale: 0, \<25%, 25-50%, 50-75%, \> 75%).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Infiltrating ductal carcinoma according the biopsy of the breast, * Tumor visible by ultrasound, smaller than 2 cm, * Located \> 1 cm from the chest wall and the skin. Exclusion Criteria: * Personal antecedents of breast cancer * Multifocality or intraductal carcinoma * Lobular infiltrating carcinoma * Neoadjuvant therapy
References
Publications (0)
Data not yet available
No reference posted for this study.